Septic cardiomyopathy.
Septic cardiomyopathy.
复制标题
DOI:
10.1097/aia.0b013e3182603ec1
复制
发表时间:
2012
影响因子:
0.6
通讯作者:
Kaynar AM
中科院分区:
文献类型:
--
作者:
Phillips DP;Kaynar AM
Myocardial depression without structural changes in patients with sepsis is termed “septic cardiomyopathy.” 1–6 Calvin et al 7 in 1981 demonstrated myocardial dysfunction in volume-resuscitated septic patients, who had decreased ejection fraction and increased enddiastolic volume index. Subsequently, using pulmonary artery catheters (PAC) with serial radionuclide imaging, Parker et al 8 furthered these observations with the 2 major findings that (a) survivors of septic shock had increased end-diastolic volume index and decreased ejection fraction, whereas nonsurvivors typically maintained normal cardiac volumes; and (b) these acute changes in end-diastolic volume index and ejection fraction, although sustained for several days, were reversible. More recently, echocardiographic studies have demonstrated impaired left ventricular systolic and diastolic function in septic patients. 9, 10 Overall, septic cardiomyopathy can be characterized by sudden (1) depression of cardiac output despite elevated levels of catecholamines;(2) decreased blood pressure response to fluid boluses;(3) reversible reduction in ejection fraction; and (4) biventricular dilation. 11–16 Patients may also have profoundly reduced stroke volumes and left ventricular ejection fractions of< 30% despite exhibiting normal left ventricular end-diastolic volumes. 14, 17, 18 Septic cardiomyopathy was believed to occur late in the sepsis continuum; however, it has been also demonstrated early in the disease state and impairs both ventricles. 4, 14, 19 Preclinical and clinical data suggest that myocardial depression occurs in the presence of elevated levels of proinflammatory cytokines. 20, 21